HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cosmetic reporting

This article was originally published in The Rose Sheet

Executive Summary

FDA is requesting public comments on Cosmetic Product Voluntary Reporting Program, agency announces in June 13 Federal Register 1notice. Information sought by FDA includes feedback on necessity of the program and ways to improve it. Agency notes electronic filing system, expected to reduce burden on manufacturers, likely will be implemented this summer. FDA estimates annual total hour burden at 742 hours, 75% of the burden reported in 2002 due to drop in submissions. "However, the number of respondents doubled, and FDA attributes this to increased interest in the program," agency states, adding it expects an uptick in submissions in the next three years. Comments are due Aug. 12...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013108

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel